Lexaria Bioscience Corp Earnings

The next earnings date for Lexaria Bioscience Corp is October 29, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Lexaria Bioscience Corp Earnings

Report Date	Estimated Earnings Per Share
01/21/2026	$-0.14
10/29/2025	$-0.16

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Lexaria Bioscience Corp Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
07/25/2025	---	$-0.21	-32.16%
07/18/2025	---	$0	100.00%
04/07/2025	After Market	$-0.15	8.14%
01/10/2025	After Market	$-0.16	-33.33%
11/19/2024	After Market	$-0.15	-36.36%
07/12/2024	After Market	$-0.13	-30.00%
04/09/2024	After Market	$-0.06	40.00%
01/12/2024	After Market	$-0.13	-18.18%
11/20/2023	After Market	$-0.12	7.69%
07/14/2023	After Market	$-0.37	-48.00%
04/14/2023	After Market	$-0.22	---
01/17/2023	After Market	$-0.30	---
11/28/2022	Before Market	$-0.24	-14.29%
07/14/2022	After Market	$-0.41	-46.43%
04/11/2022	Before Market	$-0.25	-219.05%
01/14/2022	After Market	$-0.35	---
11/29/2021	Before Market	$-0.22	4.35%
07/15/2021	After Market	$-0.50	---
04/14/2021	Before Market	$0.11	---
01/14/2021	After Market	$-0.23	---
10/15/2020	Before Market	$-0.01	---
06/30/2020	Before Market	$-0.02	---
04/03/2020	Before Market	$-0.01	---
01/08/2020	After Market	$-0.01	---
11/14/2019	Before Market	$-0.01	---
07/08/2019	Before Market	$-0.01	---
04/15/2019	After Market	$-0.01	---
01/11/2019	After Market	$-0.01	---
11/14/2018	After Market	$-0.02	---
08/01/2018	---	$-0.05	---
04/12/2018	---	$-0.02	---
01/12/2018	---	$-0.01	---
11/27/2017	---	$-0.01	---
07/14/2017	---	$-0.01	---
07/31/2014	---	$-0.07	---
04/30/2014	---	$-0.56	---
01/31/2014	---	$-0.17	---
10/31/2013	---	$-0.21	---
07/31/2013	---	$-0.10	---
04/30/2013	---	$-0.08	---
01/31/2013	---	$-0.19	---
10/31/2012	---	$0.05	---
07/31/2012	---	$0.11	---
04/30/2012	---	$-0.39	---
01/31/2012	---	$-0.20	---
10/31/2011	---	$0.00	---
07/31/2011	---	$-0.48	---
04/30/2011	---	$-0.32	---
01/31/2011	---	$-0.27	---
10/31/2010	---	$-0.17	---
07/31/2010	---	$-0.06	---
04/30/2010	---	$-0.36	---
01/31/2010	---	$-0.71	---
10/31/2009	---	$-0.27	---
07/31/2009	---	$-0.88	---
04/30/2009	---	$-0.95	---
01/31/2009	---	$-0.73	---
10/31/2008	---	$-1.46	---
07/31/2008	---	$-0.27	---
04/30/2008	---	$-2.45	---
01/31/2008	---	$-0.30	---
10/31/2007	---	$3.49	---
07/31/2007	---	$-5.69	---
04/30/2007	---	$-1.88	---
01/31/2007	---	$-1.30	---
10/31/2006	---	$-2.51	---

More About Lexaria Bioscience Corp

Website

https://lexariabioscience.com

Country

USA

Full Time Employees

Lexaria Bioscience Corp. operates as a biotechnology company. It offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. The company's DehydraTECH is used with a range of active molecules, including glucagon-like peptide-1 drugs (GLP-1) and glucose -dependent insulinotropic polypeptide drugs (GIP), vitamins, pain medications, hormones, phosphodiesterase type 5 (PDE5) inhibitors, antivirals, nicotine and its analogs, and cannabinoids. Its DehydraTECH technology is applied to various therapeutic indications, such as diabetes, weight loss, hypertension, and heart disease; is implemented in a multitude of ingestible or topically administered product formats comprising oral suspensions, tablets, capsules, foods, beverages, creams, lotions, and skin patches; and is suitable for a variety of product formats, including pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The company was formerly known as Lexaria Corp. and changed its name to Lexaria Bioscience Corp. in April 2016. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.

“Lexaria Bioscience Corp Earnings” Can Refer to the Lexaria Bioscience Corp Earnings Date

Some people say “Lexaria Bioscience Corp earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Lexaria Bioscience Corp position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Lexaria Bioscience Corp Stock on the Earnings Date

If you own Lexaria Bioscience Corp stock (LEXX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Lexaria Bioscience Corp might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Lexaria Bioscience Corp shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Lexaria Bioscience Corp Earnings

You can contact us any time if you would like to ask questions about Lexaria Bioscience Corp earnings or anything else related to the stock market.